TY - CHAP M1 - Book, Section TI - Cystic Fibrosis A1 - Wright, Chanin C. A1 - Vera, Yolanda A2 - DiPiro, Joseph T. A2 - Yee, Gary C. A2 - Posey, L. Michael A2 - Haines, Stuart T. A2 - Nolin, Thomas D. A2 - Ellingrod, Vicki PY - 2020 T2 - Pharmacotherapy: A Pathophysiologic Approach, 11e AB - KEY CONCEPTS Good nutrition with appropriate pancreatic enzyme and vitamin supplementation are essential in the management of cystic fibrosis (CF). Airway clearance and anti-inflammatory therapies are key components to improve pulmonary health in CF patients. Antipseudomonal agents are the cornerstone of antibiotic therapy for chronic lung infections in the CF patient. Altered pharmacokinetics of CF patients can impact the dosing and clearance of pharmacologic therapy. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1182435770 ER -